Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1160265 | 1.00 | THRB (0.40) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| SCHEMBL1196063 | 1.00 | THRB (0.40) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| Glycolic Acid SCHEMBL28099037 | 0.90 | FFAR3 (0.35) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| Glycine SCHEMBL29869337 | 0.88 | GLRA1 (0.46) | THRBSLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL26940409 | 0.87 | MMP1 (0.48) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| SCHEMBL9628984 | 0.87 | MMP1 (0.48) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| SCHEMBL7069046 | 0.85 | LMNA (0.38) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| SCHEMBL2963336 | 0.85 | TSHR (0.41) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| SCHEMBL11382908 | 0.83 | TDP1 (0.36) | THRBSLC1A3SLC1A2SLC1A1LMNA | |
| SCHEMBL2985403 | 0.83 | MMP1 (0.32) | THRBSLC1A3SLC1A2SLC1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 962 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-118814170-A | Pickling passivation paste and pickling passivation process of stainless steel food storage tank | 泸州老窖酿酒有限责任公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115400603-B | Nanofiltration membrane prepared based on dissociation of plant polyphenol-metal ion complex and preparation method thereof | 天津大学 | 2023-12-22 | — | — | CN | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| CN-115466530-B | Modified silicon dioxide crystal face agent and preparation method and application thereof | 武汉工程大学 | 2023-10-27 | — | — | CN | claimed |
| US-11739050-B2 | Method for purification of terpenoid amino alcohol derivatives | SCI PHARMTECH INC. (TW) | 2023-08-29 | — | — | US | claimed |
| CN-114424823-B | A soft capsule containing natural extract for reducing blood lipid and its preparation method | 江苏海王健康生物科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-6872295-B2 | Method for preparing an electroplating bath and related copper plating process | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (IMEC) (BE) | 2005-03-29 | — | — | US | claimed |
| CN-1146402-C | Gel compositions and methods | — | 2004-04-21 | — | — | CN | claimed |
| US-6663915-B2 | Immersing the substrate in a copper plating bath; immersing an activator in copper plating bath; performing a direct contact between activator and substrate to deposit copper on substrate | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (BE) | 2003-12-16 | — | — | US | claimed |
| US-20020153259-A1 | Method for preparing an electroplating bath and related copper plating process | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (IMEC) (BE) | 2002-10-24 | — | — | US | claimed |
| US-20020152926-A1 | Method for copper plating deposition | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (BE) | 2002-10-24 | — | — | US | claimed |
| EP-1215305-A1 | Method for preparing an electroplating bath and related copper plating process | INTERUNIVERSITAIR MICRO-ELEKTRONICA CENTRUM VZW (BE) | 2002-06-19 | — | — | EP | claimed |
| EP-1103633-A1 | Method for copper plating deposition | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM VZW (BE) | 2001-05-30 | — | — | EP | claimed |
| US-6045785-A | COMPRISING A STEROL SULFATE, ALUMINUM CHLOROHYDRATE, AND AN ESTERASE INHIBITOR, A BACTERICIDAL AGENT, OR A BACTERIOSTATIC AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-04-04 | — | — | US | claimed |
| CN-1240346-A | Injectable depot gel composition and method of preparing the composition | ALZA CORP (US) | 2000-01-05 | — | — | CN | claimed |
| US-5208352-A | Process for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymethyl-tetrahydrofuran and their use in preparing stereoisomers of pharmacologically active compounds | SANDOZ LTD. (CH) | 1993-05-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739050-B2 | Method for purification of terpenoid amino alcohol derivatives | ADH1A, MSMO1, MED1 | THRB 1003/4885SLC1A3 1404/4885SLC1A2 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.